NOVAKIVSKYY, V. PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION. Ukrainian Journal of Nephrology and Dialysis, n. 1(53), p. 26-31, 3 Mar. 2017.